Registrations are now open for the 2019 BridgeTech Program.
The program, which is now in its second year, is a professional development program for commercialising medical devices.
It is run by the Queensland University of Technology in collaboration with MTPConnect, the industry growth centre for the medical technology, biotechnology and pharmaceutical industries, and a range of other partners.
The partners are Agilent Technologies; IDE Group; Stryker; AusBiotech; Life Sciences Queensland; The Actuator; Cochlear; Macquarie University; University of Melbourne; Deakin University; Magnetica; University of New South Wales; Flinders University; MTAA; University of Newcastle; Gadens; Queensland University of Technology; University of Western Australia; Hydrix; and, Siemens Healthcare.
The program will select up to 100 participants from across Australia to take part in face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that contribute to research translation and the commercialisation of medical devices and diagnostics.
Applications are due by 15 February. More information and the expression of interest form is available online.